The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol

被引:15
作者
Ryan, Neil A. J. [1 ,2 ]
Blake, Dominic [3 ]
Cabrera-Dandy, Marcus [4 ]
Glaire, Mark A. [5 ,6 ]
Evans, D. Gareth [2 ]
Crosbie, Emma J. [1 ,7 ,8 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, St Marys Hosp, Manchester, Lancs, England
[2] Univ Manchester, St Marys Hosp, Div Evolut & Genom Med, Fac Biol Med & Hlth, Manchester, Lancs, England
[3] Queen Elizabeth Hosp, Northern Gynaecol Oncol Ctr, Gateshead, England
[4] Lancashire Hosp NHS Trust, Royal Blackburn Hosp, Haslingden Rd, Blackburn, Lancs, England
[5] Univ Oxford, Tumour Genom & Immunol Grp, Oxford Ctr Canc Gene Res, Wellcome Trust Ctr Human Genet, Oxford, England
[6] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[7] Univ Manchester, St Marys Hosp, NHS Fdn Trust, Dept Obstet & Gynaecol,Manchester Acad Hlth Sci C, Manchester, Lancs, England
[8] Univ Manchester, Div Canc Sci, Gynaecol Oncol Res Grp, St Marys Hosp, 5th Floor Res,Oxford Rd, Manchester M13 9WL, Lancs, England
关键词
Lynch syndrome; Endometrial cancer; Systematic review; Prevalence; Immunohistochemistry; Microsatellite instability; Next generation sequencing; NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; HIGH-RISK; PREDISPOSITION; STRATEGIES; GUIDELINES; DIAGNOSIS;
D O I
10.1186/s13643-018-0792-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lynch syndrome is the most common inherited cancer syndrome, which predisposes individuals to a number of different cancers, principally colorectal and endometrial cancer. The early diagnosis of Lynch syndrome enables colorectal surveillance, which has been shown to save lives through the detection and removal of premalignant polyps and earlier detection of invasive disease. Endometrial cancer, which is often the sentinel cancer in women, provides an opportunity to diagnose Lynch syndrome and thus enable colorectal surveillance as well as the cascade testing for Lynch syndrome in other family members. These potential benefits have led to a call for the universal screening of women with endometrial cancer for Lynch syndrome, a practice that is now commonplace in colorectal cancer. Healthcare providers and clinicians are however restricted by insufficient knowledge about the prevalence of Lynch syndrome in women with endometrial cancer, with estimates varying as widely as 1-10%. The aim of this study is to perform a systematic review with a meta-analysis of the current literature base in order to estimate the prevalence of Lynch syndrome among women with endometrial cancer to inform this discussion. Methods: Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Methodology Register, NHS Health and Technology Assessment Database and the Web of Science will be systematically searched for relevant studies via the Ovid platform. Two authors will review the titles and abstracts independently, with discrepancy settled by a third author. Data extraction will be completed to record demographic, pathological and clinical data, as well as the diagnostic methods used for estimating the prevalence of Lynch syndrome in women with endometrial cancer. Bias will be assessed and recorded using the Newcastle-Ottawa Scale and that of the International Cochrane Collaboration. Dependent on the heterogeneity of the data, we aim to produce a cumulative incidence in addition to subgroup analyses as to investigate secondary outcomes. Discussion: The aim of this systematic review is to provide a robust estimate of the prevalence of Lynch syndrome in women with endometrial cancer. This will enable resource allocation and decision-making regarding the appropriateness of screening all women, or certain women, with endometrial cancer for Lynch syndrome. Such a policy could enable the earlier diagnosis of Lynch syndrome in women and, through the application of colorectal cancer surveillance, improve their survival outcomes.
引用
收藏
页数:6
相关论文
共 24 条
  • [1] [Anonymous], MOL TEST STRAT LYNCH
  • [2] Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for lynch syndrome
    Batte, Brittany A. L.
    Bruegl, Amanda S.
    Daniels, Molly S.
    Ring, Kari L.
    Dempsey, Katherine M.
    Djordjevic, Bojana
    Luthra, Rajyalakshmi
    Fellman, Bryan M.
    Lu, Karen H.
    Broaddus, Russell R.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 319 - 325
  • [3] Boland CR, 1998, CANCER RES, V58, P5248
  • [4] Buchanan DD, 2013, JCO, V32
  • [5] Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
    Cairns, Stuart R.
    Scholefield, John H.
    Steele, Robert J.
    Dunlop, Malcolm G.
    Thomas, Huw J. W.
    Evans, Gareth D.
    Eaden, Jayne A.
    Rutter, Matthew D.
    Atkin, Wendy P.
    Saunders, Brian P.
    Lucassen, Anneke
    Jenkins, Paul
    Fairclough, Peter D.
    Woodhouse, Christopher R. J.
    [J]. GUT, 2010, 59 (05) : 666 - 689
  • [6] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Colombo, N.
    Preti, E.
    Landoni, F.
    Carinelli, S.
    Colombo, A.
    Marini, C.
    Sessa, C.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : vi35 - vi39
  • [7] Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
    Goodfellow, Paul J.
    Billingsley, Caroline C.
    Lankes, Heather A.
    Ali, Shamshad
    Cohn, David E.
    Broaddus, Russell J.
    Ramirez, Nilsa
    Pritchard, Colin C.
    Hampel, Heather
    Chassen, Alexis S.
    Simmons, Luke V.
    Schmidt, Amy P.
    Gao, Feng
    Brinton, Louise A.
    Backes, Floor
    Landrum, Lisa M.
    Geller, Melissa A.
    DiSilvestro, Paul A.
    Pearl, Michael L.
    Lele, Shashikant B.
    Powell, Matthew A.
    Zaino, Richard J.
    Mutch, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (36) : 4301 - +
  • [8] Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
    Hampel, Heather
    Frankel, Wendy
    Panescu, Jenny
    Lockman, Janet
    Sotamaa, Kaisa
    Fix, Daniel
    Comeras, Ilene
    La Jeunesse, Jennifer
    Nakagawa, Hidewaki
    Westman, Judith A.
    Prior, Thomas W.
    Clendenning, Mark
    Penzone, Pamela
    Lombardi, Janet
    Dunn, Patti
    Cohn, David E.
    Copeland, Larry
    Eaton, Lynne
    Fowler, Jeffrey
    Lewandowski, George
    Vaccarello, Luis
    Bell, Jeffrey
    Reid, Gary
    de la Chapelle, Albert
    [J]. CANCER RESEARCH, 2006, 66 (15) : 7810 - 7817
  • [9] Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables
    Joehlin-Price, Amy S.
    Perrino, Carmen M.
    Stephens, Julie
    Backes, Floor J.
    Goodfellow, Paul J.
    Cohn, David E.
    Suarez, Adrian A.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 43 - 47
  • [10] Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
    Kempers, Marlies J. E.
    Kuiper, Roland P.
    Ockeloen, Charlotte W.
    Chappuis, Pierre O.
    Hutter, Pierre
    Rahner, Nils
    Schackert, Hans K.
    Steinke, Verena
    Holinski-Feder, Elke
    Morak, Monika
    Kloor, Matthias
    Buettner, Reinhard
    Verwiel, Eugene T. P.
    van Krieken, J. Han
    Nagtegaal, Iris D.
    Goossens, Monique
    van der Post, Rachel S.
    Niessen, Renee C.
    Sijmons, Rolf H.
    Kluijt, Irma
    Hogervorst, Frans B. L.
    Leter, Edward M.
    Gille, Johan J. P.
    Aalfs, Cora M.
    Redeker, Egbert J. W.
    Hes, Frederik J.
    Tops, Carli M. J.
    van Nesselrooij, Bernadette P. M.
    van Gijn, Marielle E.
    Garcia, Encarna B. Gomez
    Eccles, Diana M.
    Bunyan, David J.
    Syngal, Sapna
    Stoffel, Elena M.
    Culver, Julie O.
    Palomares, Melanie R.
    Graham, Tracy
    Velsher, Lea
    Papp, Janos
    Olah, Edith
    Chan, Tsun L.
    Leung, Suet Y.
    van Kessel, Ad Geurts
    Kiemeney, Lambertus A. L. M.
    Hoogerbrugge, Nicoline
    Ligtenberg, Marjolijn J. L.
    [J]. LANCET ONCOLOGY, 2011, 12 (01) : 49 - 55